PDC Therapeutics
PrivateLast Round
Series A
Dec 15, 2021
Total Funding Raised
$14.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PDC Therapeutics operates in Healthcare & Life Sciences and is based in Epalinges. Its latest recorded funding round was a Series A round in December 2021.
PDC Therapeutics is a biotechnology company that develops targeted Polymer-Drug Conjugate technologies for cancer therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PDC Therapeutics Comparables
Compare PDC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cybrexa Therapeutics | 82% | |
| Beihai Biotech | 77% | |
| OncoNano Medicine | 74% |
For institutional investors. Book with your work email.
PDC Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PDC Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Partners | Seed |
| İstanbul Portföy Yönetimi | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 239% MoM, reaching 1.7K.
- May 11, 2026
Monthly visitors increased 374% MoM, from 358 to 1.7K.
For institutional investors. Book with your work email.
PDC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PDC Therapeutics's valuation, stock price, and market status.
Is PDC Therapeutics a public or private company?
PDC Therapeutics is a private company.
What is the current stock price of PDC Therapeutics?
PDC Therapeutics is a private company, so its shares have no public market price. Caplight tracks PDC Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PDC Therapeutics worth (valuation)?
Valuation information for PDC Therapeutics is not publicly available.
Can I buy PDC Therapeutics stock?
PDC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PDC Therapeutics's last funding round?
PDC Therapeutics's most recent funding round was Series A on December 15, 2021.
Who are the main investors in PDC Therapeutics?
Key investors in PDC Therapeutics include ACT Venture Partners, İstanbul Portföy Yönetimi.
Will PDC Therapeutics IPO soon?
No public IPO plans have been announced for PDC Therapeutics.
How can I track PDC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PDC Therapeutics's shares on secondary markets.